Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

On February 13, Ronald E. Blaylock, a director at Pfizer Inc. (NYSE:PFE), purchased 19,457 shares of the company's common stock. The transaction was valued at a total of $499,072, with each share ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...

There were people on the Pfizer board, allegedly ... Antony Blinken, Mike Morell—the former CIA director, interim director—they got 51 people, right before the Oct. 23 debate, to lie ...

Mumbai: Pfizer has announced that Sandeep Seth, Senior Director - Compliance, has tendered his resignation from the services of the Company.His departure will be effective from the close ...

In a move that will raise eyebrows in Washington, Pfizer has hired the former director of the FDA's Center for Drug Evaluation and Research (CDER), Patricia Cavazzoni, as its new chief medical ...

March 5 - Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab won a round in their legal battle with Moderna (MRNA.O), opens new tab over COVID-19 vaccine patents on Wednesday ...

Equities research analysts at Zacks Research reduced their Q2 2026 earnings per share (EPS) estimates for Pfizer in a report issued on Thursday, March 20th. Zacks Research analyst K. Shah now ...